BioCareSD April 2024 Product Catalog

IG IMMUNOLOGY - IMMUNOGLOBULIN PRODUCTS Product Name Package Size NDC # Presentation Product Category Subcategory

NP NEUROLOGY PRODUCTS Product Name Package Size NDC #

Product Category Subcategory

Derivation

Manufacturer

Presentation

Derivation

Manufacturer

SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS

TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC. TAKEDA PHARMACEUTICALS AMERICAS, INC.

KEPPRA

250 MG 50474-0594-40

BOTTLE

NEUROLOGY

LEVETIRACETAM

UCB, INC.

HYQVIA

5 GRAM 00944-2511-02

VIAL

IMMUNOLOGY SUBCUTANEOUS IMMUNE GLOBULIN PLASMA

KEPPRA

500 MG 50474-0595-40

BOTTLE

NEUROLOGY

LEVETIRACETAM

UCB, INC.

HYQVIA

10 GRAM 00944-2512-02

VIAL

IMMUNOLOGY SUBCUTANEOUS IMMUNE GLOBULIN PLASMA

KEPPRA

750 MG 50474-0596-40

BOTTLE

NEUROLOGY

LEVETIRACETAM

UCB, INC.

HYQVIA

20 GRAM 00944-2513-02

VIAL

IMMUNOLOGY SUBCUTANEOUS IMMUNE GLOBULIN PLASMA

KEPPRA

1000 MG 50474-0597-66

BOTTLE

NEUROLOGY

LEVETIRACETAM

UCB, INC.

HYQVIA

30 GRAM 00944-2514-02

VIAL

IMMUNOLOGY SUBCUTANEOUS IMMUNE GLOBULIN PLASMA

KEPPRA XR

500 MG 50474-0598-66

BOTTLE

NEUROLOGY

LEVETIRACETAM

UCB, INC.

XEMBIFY

1 GRAM 13533-0810-05

VIAL

IMMUNOLOGY SUBCUTANEOUS IMMUNE GLOBULIN PLASMA

GRIFOLS USA, LLC

KEPPRA XR

750 MG 50474-0599-66

BOTTLE

NEUROLOGY

LEVETIRACETAM

UCB, INC.

LEQEMBI

200 MG / 2 ML

62856-0212-01

VIAL

NEUROLOGY

LECANEMAB

EISAI INC.

XEMBIFY

2 GRAM 13533-0810-10

VIAL

IMMUNOLOGY SUBCUTANEOUS IMMUNE GLOBULIN PLASMA

GRIFOLS USA, LLC

LEQEMBI

500 MG / 5 ML

62856-0215-01

VIAL

NEUROLOGY

LECANEMAB

EISAI INC.

XEMBIFY

4 GRAM 13533-0810-20

VIAL

IMMUNOLOGY SUBCUTANEOUS IMMUNE GLOBULIN PLASMA

GRIFOLS USA, LLC

VIMPAT INJECTION*

200 MG / 20 ML

00131-1810-67

VIAL

NEUROLOGY

LACOSAMIDE

UCB, INC.

XEMBIFY

10 GRAM 13533-0810-50

VIAL

IMMUNOLOGY SUBCUTANEOUS IMMUNE GLOBULIN PLASMA

GRIFOLS USA, LLC

VIMPAT*

50 MG

00131-2477-35

BOTTLE

NEUROLOGY

LACOSAMIDE

UCB, INC.

VIMPAT*

50 MG

00131-2477-60 UNIT DOSE PACK NEUROLOGY

LACOSAMIDE

UCB, INC.

NP NEUROLOGY PRODUCTS Product Name Package Size NDC #

VIMPAT*

100 MG

00131-2478-35

BOTTLE

NEUROLOGY

LACOSAMIDE

UCB, INC.

Product Category Subcategory

VIMPAT*

100 MG

00131-2478-60 UNIT DOSE PACK NEUROLOGY

LACOSAMIDE

UCB, INC.

Presentation

Derivation

Manufacturer

VIMPAT*

150 MG

00131-2479-35

BOTTLE

NEUROLOGY

LACOSAMIDE

UCB, INC.

AMYOTROPHIC LATERAL SCLEROSIS (ALS)

VIMPAT*

150 MG

00131-2479-60 UNIT DOSE PACK NEUROLOGY

LACOSAMIDE

UCB, INC.

AMYOTROPHIC LATERAL SCLEROSIS (ALS)

MITSUBISHI TANABE PHARMA AMERICA, INC.

RADICAVA

30MG/100 ML

70510-2171-02

CARTON

NEUROLOGY

RECOMBINANT

VIMPAT*

200 MG

00131-2480-35

BOTTLE

NEUROLOGY

LACOSAMIDE

UCB, INC.

VIMPAT*

200 MG

00131-2480-60 UNIT DOSE PACK NEUROLOGY

LACOSAMIDE

UCB, INC.

SEIZURE DISORDERS

VIMPAT ORAL SOLUTION*

10 MG / ML

00131-5410-72

BOTTLE

NEUROLOGY

LACOSAMIDE

UCB, INC.

SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS SEIZURE DISORDERS

BRIVIACT*

10 MG

50474-0370-66

BOTTLE

NEUROLOGY

BRIVARACETAM

UCB, INC.

PARKINSON'S DISEASE

BRIVIACT*

25 MG

50474-0470-09 UNIT DOSE PACK NEUROLOGY

BRIVARACETAM

UCB, INC.

NEUPRO

30 X 1 MG 50474-0801-03

EACH

NEUROLOGY PARKINSON'S DISEASE DOPAMINE AGONISTS NEUROLOGY PARKINSON'S DISEASE DOPAMINE AGONISTS NEUROLOGY PARKINSON'S DISEASE DOPAMINE AGONISTS NEUROLOGY PARKINSON'S DISEASE DOPAMINE AGONISTS NEUROLOGY PARKINSON'S DISEASE DOPAMINE AGONISTS NEUROLOGY PARKINSON'S DISEASE DOPAMINE AGONISTS

UCB, INC.

BRIVIACT*

25 MG

50474-0470-66

BOTTLE

NEUROLOGY

BRIVARACETAM

UCB, INC.

NEUPRO

30 X 2 MG 50474-0802-03

EACH

UCB, INC.

NEUPRO

30 X 3 MG 50474-0803-03

EACH

UCB, INC.

BRIVIACT*

50 MG

50474-0570-09 UNIT DOSE PACK NEUROLOGY

BRIVARACETAM

UCB, INC.

NEUPRO

30 X 4 MG 50474-0804-03

EACH

UCB, INC.

BRIVIACT*

50 MG

50474-0570-66

BOTTLE

NEUROLOGY

BRIVARACETAM

UCB, INC.

NEUPRO

30 X 6 MG 50474-0805-03

EACH

UCB, INC.

BRIVIACT*

75 MG

50474-0670-66

BOTTLE

NEUROLOGY

BRIVARACETAM

UCB, INC.

NEUPRO

30 X 8 MG 50474-0806-03

EACH

UCB, INC.

BRIVIACT*

100 MG 50474-0770-09 UNIT DOSE PACK NEUROLOGY

BRIVARACETAM

UCB, INC.

OP OPHTHALMOLOGY / RETINA Product Name Package Size

BRIVIACT*

100 MG 50474-0770-66

BOTTLE

NEUROLOGY

BRIVARACETAM

UCB, INC.

BRIVIACT ORAL SOLUTION*

10 MG / ML

50474-0870-15

BOTTLE

NEUROLOGY

BRIVARACETAM

UCB, INC.

NDC # Presentation Product Category

Subcategory

Derivation

Manufacturer

BRIVIACT INJECTION*

50 MG / 5 ML

50474-0970-75

VIAL

NEUROLOGY

BRIVARACETAM

UCB, INC.

THYROID EYE DISEASE (TEPROTUMUMAB-TRBW)

OPHTHALMOLOGY/ RETINA

THYROID EYE DISEASE

MONOCLONAL ANTIBODY

NAYZILAM*

5 MG

50474-0500-15

NASAL SPRAY

NEUROLOGY

BENZODIAZEPINES

UCB, INC.

TEPEZZA

500 MG 75987-0130-15

VIAL

HORIZON THERAPEUTICS

NEUROMYELITIS OPTICA SPECTRUM DISORDER (NMOSD)

KEPPRA ORAL SOLUTION 100 MG / ML

50474-0001-48

BOTTLE

NEUROLOGY

LEVETIRACETAM

UCB, INC.

NEUROMYELITIS OPTICA SPECTRUM DISORDER

MONOCLONAL ANTIBODY

KEPPRA INJECTION

500 MG / 5ML 50474-0002-63

VIAL

NEUROLOGY

LEVETIRACETAM

UCB, INC.

UPLIZNA

3 PACK

72677-0551-01

EACH OPHTHALMOLOGY/ RETINA

HORIZON THERAPEUTICS

21

Powered by